# YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus

> **NCT01836172** · PHASE2 · UNKNOWN · sponsor: **Han Wha Pharma Co., Ltd.** · enrollment: 136 (estimated)

## Conditions studied

- Diabetic Complication

## Interventions

- **DRUG:** YJP-14

## Key facts

- **NCT ID:** NCT01836172
- **Lead sponsor:** Han Wha Pharma Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-04
- **Primary completion:** 2016-12
- **Final completion:** 2017-01
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2016-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01836172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01836172, "YJP-14 Capsules for the Treatment of Endothelial Dysfunction in Patients With Diabetes Mellitus". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01836172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*